Valuation (14%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -6.77 | N/A |
| PEG Ratio (TTM) | -0.07 | N/A |
| P/S Ratio (TTM) | N/A | N/A |
| P/B Ratio (TTM) | 0.70 | N/A |
| P/FCF Ratio (TTM) | -17.60 | N/A |
| Price to 5YR AVG Earnings Ratio | -5.89 | N/A |
| Price to 5YR AVG FCF Ratio | -13.97 | N/A |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -6.92% | N/A |
| ROE (TTM) | -9.94% | N/A |
| Net Profit Margin (TTM) | N/A | N/A |
| ROIC 5YR AVG | -1.56% | N/A |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 16.87% | -19.78% | -23.45% |
| Revenue | N/A | N/A | N/A |
| Net Income | 13.76% | -33,284.17% | -19,982.75% |
| Cash Flow | -18.08% | -35,587.14% | -21,353.10% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.13 | N/A |
| Quick Ratio (TTM) | 0.11 | N/A |
| D/E Ratio (TTM) | 0.29 | N/A |
| Interest Coverage (TTM) | -1.22 | N/A |
| Piotroski F-Score | 2 | N/A |
| Altman Z-Score | 5.86 | N/A |
| LTL to 5YR AVG FCF | -0.01 | N/A |
| Shares Outstanding Growth 5YR AVG | 21,790.32% | N/A |